Search

everythinglearnresearchcommunity

for

Search:↓

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Some people may temporarily lose more hair in certain areas after a hair transplant.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

Lichen planopilaris can be accurately diagnosed and effectively treated.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

Damage to hair follicle stem cells may cause permanent hair loss and scarring in PCA.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

FFA and FAPD might be related or stages of the same disease.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.